Early cardiac involvement in senile systemic amyloidosis: A case report

Amyloid

Volumn 15, Issue 1, 2008, Pages 54-59

  Yamano, Michiyo ^a,d   Azuma, Akihiro ^b   Yazaki, Masahide ^c   Ikeda, Shu Ichi ^c   Sawada, Takahisa ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Higashi ohmi General Medical Center   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

Amyloid; Amyloid heart disease; Cardiac amyloidosis; Cardiomyopathy; Transthyretin

Indexed keywords

PREALBUMIN;

AGED; AMYLOIDOSIS; ANTIBODY LABELING; ARTICLE; BRAIN EMBOLISM; BRAIN INFARCTION; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; EMBOLISM; HEART AMYLOIDOSIS; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SYSTEMIC DISEASE;

AGED; AMYLOIDOSIS; BIOPSY; CEREBRAL INFARCTION; EMBOLISM; HEART DISEASES; HUMANS; MALE;

EID: 39049094793     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120701815506     Document Type: Article

References (30)

1. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva M, Sipe JD. Amyloid: toward terminology clarification. Report from the nomenclature committee of the international society of amyloidosis. Amyloid. The Journal of Protein Folding Disorders 2005;12:1-4.
2. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45-59.
3. Cornwell GG 3rd, Murdoch WL, Kyle RA, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618-623.
4. Westermark P, Bergström J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid. The Journal of Protein Folding Disorders 2003;10(Suppl. 1):48-54.
5. Wizenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J 1982;103:468-473.
6. Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, Takahashi M, Ishihara T. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain contrast region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001;51:264-270.
7. Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y-F, Masuda Y, Ikeda S. Usefulness of MALD-TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid. The Journal of Protein Folding Disorders 1999;6:282-288.
8. Ikeda S. Cardiac amyloidosis: heterogenous pathogenic backgrounds. Intern Med 2004;43:1107-1114.
9. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Med 1998;91:141-157.
10. Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan. Clinical and genetic heterogeneity. Neurology 2002;58:1001-1007.
11. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid. The Journal of Protein Folding Disorders 2003;10:160-184.
12. Takahashi K, Sakashita N, Ando Y, Suga M, Ando M. Late onset type I familial amyloidotic polyneuropathy: presentation of three autopsy cases in comparison with 19 autopsy cases of ordinary type. Pathol Int 1997;47:353-358.
13. Westermark P, Sletten K, Johansson B, Cornwell GG 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843-2845.
14. Kyle RA, Spittell PC, Gertz MA, Li C-Y, Edwards WD, Olson LJ, Thibodeau SN. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;171:395-400.
15. Takei Y, Hattori T, Gono T, Tokuda T, Saitoh S, Hoshii Y, Ikeda S. Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome. Amyloid. The Journal of Protein Folding Disorders 2002;9:252-255.
16. Takei Y, Hattori T, Tokuda T, Matsuda M, Saitoh T, Hoshii Y, Ikeda S. Senile systemic amyloidosis starting as bilateral carpal and left ulnar tunnel syndrome. Intern Med 2003;42:1050-1051.
17. Johanson B, Westermark P. Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991;32:83-92.
18. Olson LJ, Gertz MA, Edwards WD, Li C-Y, Pellikka PA, Holmes DR, Tajik AJ, Kyle RA. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 1987;317:738-742.
19. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989;83:836-843.
20. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997;336:466-473.
21. Belinda Ng, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure. Arch Intern Med 2005;265:1425-1429.
22. Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Amyloid. The Journal of Protein Folding Disorders 2003;10:229-239.
23. Ogiwara F, Koyama J, Ikeda S, Kinoshita O, Falk RH. Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol 2005;95:538-540.
24. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004;140:85-93.
25. Gono T, Matsuda M, Shimojima Y, Ishii W, Koyama J, Sakashita K, Kioke K, Hoshii Y, Ikeda S. VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese experience and criteria for patient selection. Amyloid. The Journal of Protein Folding Disorders 2004;11:245-256.
26. Fuchs U, Zittermann A, Suhr O, Holmgren G, Tenderich G, Minami K, Koerfer R. Heart transplantation in a 68-year-old patient with senile systemic amyloidosis. Am J Transplant 2005;5:1159-1162.
27. Rice GPA, Ebers GC, Newland F, Wysocki GP. Recurrent cerebral embolism in cardiac amyloidosis. Neurology 1981;31:904-906.
28. Owa M, Takei Y, Hashikura Y, Kawasaki S, Koyama M, Ikeda S. Recurrent cerebral embolism in a familial amyloid polyneuropathy patient who received partial liver transplantation from a living donor. Intern Med 2001;40:259-264.
29. Miller SR, Sekijima S, Kelly JW. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants. Lab Invest 2004;84:545-552.
30. Tojo K, Sekijima Y, Kelly JW, Ikeda S. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis. Neurosci Res 2006;56:441-449.